Non-Indians have benefited most from patent regime in India
thehindu.com
thehindu.com
I wonder what the majority of the Indian people would prefer. What percentage of citizens of the Republic of India can actually afford the products of companies like Novartis AG when they demand patent licenses, and how much taxes would be free up by abolishing the patent office and patent enforcement?
This is a simplistic view. After the molecule was discovered, the patent certainly lowers the supply, but if the patent is what enables the molecule to be discovered in the first place, then it actually increases the supply.
Of course, whether the claim holds is questionable, but it's not like these drugs where flowing from the trees until the bad government came and limited it.
As for the taxes, I don't know the Indian patent office, but the US counterpart makes money.
Or to put it in concert fashion, should a farmer sacrifice a family member to a sickness today, just so he might be able in 20+ years buy a generic version when the price has gone down? If put to a vote, would the majorly of the citizen inside a country vote to vow never allow anyone die just because they are too poor to pay the medicine, or do they rather want the chance of increased new medicines which only a small minority can afford in the next 20+ years?
What would the democratic vote say? My bet would be on the living and not on the patents.
http://thelastpsychiatrist.com/2005/10/if_france_gets_its_wa...
And getting mad at Novartis in this case for "evergreening" also isn't entirely fair, because up until 2003/5 India was the wild west when it came to drugs, and thus Novartis couldn't really sell it there anyway. If India had product patents when Gleevec was invented in 1995, maybe they would be on course to have the generic soon. Instead, the rest of the world is subsidizing cheap drugs for India. We invent, we pay, they benefit.
Of course, evergreening is an extra evil in itself, and lets not forget that pharma also get a extra special monopoly after the patent has expired just for doing drug trials.
To get back to the topic, Non-Indians may benefit from the patent regime; but they got the products here in the first place. In short, the "refutation" is a simple quid pro quo: the foreigners manufacture most drugs, and they get the most patents. There is no argument here on whether patents are bad, it is a stupid defense of an idiotic method of patent grants. Most Indian pharma firms have no meaningful R&D, they make their profits on generics. Socialists like the present government will never understand a free market, if they want these expensive drugs for free, they have to pay for them somehow. Not by abusing a bad patent system which is protectionist. Either they should abolish patents (which is the best way) and take the results, or they start applying patents the ostensible way they are meant to be applied, which is to pay attention to whether the pharma breakthrough is big enough to merit a patent, or not.
Can you substantiate your claim that the present government in India is socialist and that they don't understand free markets?
Also, the article does not talk about free drugs?
How are you to attract foreign investment, if you limit the returns that leave the country?
[1] http://swaminomics.org/west-should-learn-from-indias-high-pa...
1. In April, India's Supreme Court denied Novartis' patent application for its cancer drug Glivec. They reasoned that Novartis was "evergreening" the drug, and thus did not deserve a patent for a new drug - http://articles.economictimes.indiatimes.com/2013-04-02/news...
2. Novartis complained, naturally - http://www.novartis.com/newsroom/media-releases/en/2013/1689...
[Edited: a couple of typos]
Nevertheless, indeed non-Indians have benefited (no offense) but that is due to people in India, specially Entrepreneurs waking up late to importance of IP.
Just Yesterday, I was attending the NASSCOM EMERGENCE CONCLAVE, where Founder of Naukri.com (India's biggest job portal) was speaking.
He revealed that it was Naukri.com FOUNDERS who first digitally collected trademark data in India, in 1989, which was about 80,000 applications, the biggest share out of total 6 lakh pending applications. They sent it to each pharmaceutical company, and made a huge profit out of it. Prior to founding Naukri.com
Though we are talking about patents here, that reference gives us a pretty good idea about the situation in India, in 1990s, when most of IP data was still in fat registers. He hired around 7-8 young college goers at intern prices, had them skip classes, and in 3 weeks collected two big bags full of registers. Which they then put throw a computer they got to use (pre pentium generation) from 10 pm to 4 am.
Today, the pending copyright applications stand at 14 lakh
1 lakh = 100,000 : For quick reference.